Archive | Presentations RSS feed for this section

PPMI Diffusion Tensor Imaging data presented at AD/PD 2013 in Florence, Italy

Yu Zhang from the University of California at San Francisco presented data on the visualization and quantification of the striato-pallidonigral fibers in PD using DTI at the 11th International Conference on Alzheimer's and Parkinson's Diseases in Florence, Italy.

Continue reading...

PPMI Scientific Leadership to Present on PPMI at 2013 SNMMI Annual Meeting

John Seibyl, member of the PPMI Steering Committee, will present on the initial quantitative 123-I Ioflupane SPECT one year disease progression data in the PPMI PD cohort.at The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting

Continue reading...

MDS 2013 Poster: “Relationship between Serum Urate and Clinical Features in Early Parkinson’s Disease: PPMI Baseline Data”

A poster submitted by Radu Constantinescu, MD of the Center for Human Experimental Therapeutics (CHET) at the University of Rochester Medical Center has been accepted for the poster session at the Movement Disorder Society’s International Congress this June in Sydney, Australia.

Continue reading...

Feasibility and Safety of Lumbar Punctures in PPMI presented at AAN

Boston University PPMI Site Principal Investigator, Samuel Frank, presented data on the feasibility and safety of lumbar punctures in PPMI at the American Academy of Neurology’s 75th annual meeting on March 19th, 2013 in San Diego, CA.

Continue reading...

PPMI Bioanalytics Core PI presented at the International Conference on Alpha-Synuclein in Dubai, UAE

Dr. Trojanowski, PI of the PPMI Bioanalytics Core presented on early Synuclein analyses that have been done in PPMI during the Biomarkers session at the International Conference on Alpha-Syunclein in Parkinson’s Disease on March 3, 2013 at 9:45 AM in Dubai. For more information on this presentation, please visit our new Presentations section of the website.

Continue reading...

Select Preliminary Baseline Data for 90% of Cohort Recruited is Presented at AAN

PPMI senior leadership presented PPMI data collected so far at the American Academy of Neurology’s 75th annual meeting. The poster used baseline data to give a preliminary sense of the characteristics of the PPMI cohort. The poster also highlights CSF acquisition success rates in PPMI and data from baseline DaTSCANs.

Continue reading...

PPMI Scientific Leadership to Present at AD/PD 2013 in Florence, Italy

AD/PD 2013 will take place in Florence, Italy from March 6th to the 10th. Three members of the PPMI Steering Committee will be presenting on the PPMI Baseline Cohort and various imaging modalities included in the study.

Continue reading...

Dr. John Q. Trojanowski to Present on PPMI at the International Conference on Alpha-Synuclein in Parkinson’s Disease and Related Neurodegenerative Diseases

Dr. Trojanowski, PI of the PPMI Bioanalytics Core will present on PPMI during the Biomarkers session at the International Conference on Alpha-Syunclein in Parkinson’s Disease on March 3, 2013 at 9:45 AM in Dubai. His talk will focus on the early Synuclein analyses that have been done in PPMI and preliminary findings on a subset of PPMI samples.

Continue reading...

Biomarkers for Brain Disorders Presentation on PPMI

Dr. Ken Marek, PPMI Study PI, will attend the Biomarkers for Brain Disorders meeting in Cambridge, UK on February 5, 2013.

Continue reading...

PPMI presented in five posters at the Movement Disorder Society International Congress

The five posters that were presented at MDS 2012 in Dublin are now posted.

Continue reading...